Back

American Society of Cytopathology

  • Biopsy, Fine-Needle
  • Biopsy, Large-Core Needle

WHO’s Who in Breast Cytology: Case-Based Overview of WHO Reporting System for Breast Cytopathology

Breast fine-needle aspiration (FNA) is an inexpensive, minimally-invasive, well-tolerated technique that provides rapid and accurate diagnosis. Over recent years, the number of breast FNA procedures has dramatically decreased in many medically well-resourced countries. This decline is largely due to the rise of popularity of core-needle biopsy, which is perceived to have higher diagnostic accuracy. Breast FNA cytology and core-needle biopsy each provide complementary roles. There is tremendous value in maintaining competency and skill in breast FNAs. The WHO System for Reporting Breast Cytopathology will provide an update to the IAC Yokohama System and will serve as an organized approach to classifying breast FNA samples. This presentation will review the WHO System and apply it to common entities in a case-based approach, including morphologic mimics and immunocytochemical pitfalls.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 2 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

$105

Standard

Listed by the provider · education.cytopathology.org

  • Case-based learning
  • includes Board review / self-assessment
  • Credit · Up to 2 credits
  • $105
  • Released
    Nov 25, 2025
  • Last day to claim credit
    Nov 25, 2028 2 years left